Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study-Reference-Cited by-同舟云学术

Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study

Published:2013-02-15 Issue:3 Volume:34 Page:1595-1603
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Lee Sang-Woon,Kim Seong-Gon,Park Young-Wook,Kweon HaeYong,Kim Jwa-Young,Rotaru Horatiu

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-013-0690-6.pdf

Reference45 articles.

1. Rapini RP, Golitz LE, Greer RO, et al. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer. 1985;55:1543–51.

2. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000;36:152–69.

3. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.

4. Tanaka N, Mimura M, Ogi K, et al. Primary malignant melanoma of the oral cavity: assessment of outcome from the clinical records of 35 patients. Int J Oral Maxillofac Surg. 2004;33:761–5.

5. Barker BF, Carpenter WM, Daniels TE, et al. Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:672–9.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Hexylresorcinol as Histone Deacetylase Inhibitor;Biomedical Application of 4-Hexylresorcinol;2024

2. Anticancer Effects of 4-Hexylresorcinol;Biomedical Application of 4-Hexylresorcinol;2024

3. Inhibition of TP53 Mutant Oral Cancer by Reactivating p53;Applied Sciences;2022-06-10

4. 4-Hexylresorcinol: pharmacologic chaperone and its application for wound healing;Maxillofacial Plastic and Reconstructive Surgery;2022-02-01

5. The effect of 4-hexylresorinol administration on NAD+ level and SIRT activity in Saos-2 cells;Maxillofacial Plastic and Reconstructive Surgery;2021-11-01